These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7004158)

  • 1. The clinical use of intravenous verapamil.
    Schamroth L
    Am Heart J; 1980 Dec; 100(6 Pt 2):1070-5. PubMed ID: 7004158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verapamil in cardiac arrhythmias: an overview.
    Vohra J
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():129-34. PubMed ID: 6749351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiology and pharmacology of cardiac arrhythmias. VI. Cardiac effects of verapamil.
    Rosen MR; Wit AL; Hoffman BF
    Am Heart J; 1975 May; 89(5):665-73. PubMed ID: 1091129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of verapamil.
    Singh BN; Nademanee K; Feld G
    Angiology; 1983 Sep; 34(9):572-90. PubMed ID: 6351674
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with verapamil.
    Vohra J; Hunt D; Sloman G
    Med J Aust; 1975 Sep; 2(11):417-21. PubMed ID: 1186549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of intravenous verapamil in cardiac arrhythmias.
    Slome R
    S Afr Med J; 1973 Jun; 47(21):913-4. PubMed ID: 4711004
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of arrhythmias with "calcium antagonists".
    Zipes DP; Gilmour RF
    Angiology; 1982 Aug; 33(8):540-54. PubMed ID: 6287890
    [No Abstract]   [Full Text] [Related]  

  • 8. Verapamil in life-threatening tachyarrhythmias.
    Gotsman MS; Lewis BS; Bakst A; Mitha AS
    S Afr Med J; 1972 Dec; 46(51):2017-9. PubMed ID: 4651883
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias.
    Rinkenberger RL; Prystowsky EN; Heger JJ; Troup PJ; Jackman WM; Zipes DP
    Circulation; 1980 Nov; 62(5):996-1010. PubMed ID: 7418184
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.
    Heng MK; Singh BN; Roche AH; Norris RM; Mercer CJ
    Am Heart J; 1975 Oct; 90(4):487-98. PubMed ID: 1163442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Slow channel calcium antagonists in the treatment of supraventricular tachycardia.
    Talano JV; Tommaso C
    Prog Cardiovasc Dis; 1982; 25(2):141-56. PubMed ID: 6180453
    [No Abstract]   [Full Text] [Related]  

  • 12. Verapamil and the heart: Pharmacological and Therapeutic Considerations.
    DPhil BN
    N Z Med J; 1975 Nov; 82(552):339-43. PubMed ID: 1061888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Four years of clinical experience with the cardio-eurhythmic action of verapamil in intravenous administration].
    Piccini A; Malfatti S
    Minerva Med; 1975 May; 66(39):1923-31. PubMed ID: 48221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verapamil therapy in the treatment of supraventricular arrhythmias following open heart surgery.
    Waldo AL; Plumb VJ; Arciniegas JG; Henthorn RW; Zimmern SH
    Angiology; 1983 Dec; 34(12):755-63. PubMed ID: 6660591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of the antiarrhythmic effect of Verapamils].
    Filias N; Zanoni G
    Schweiz Med Wochenschr; 1972 Mar; 102(12):406-9. PubMed ID: 5020522
    [No Abstract]   [Full Text] [Related]  

  • 16. [The antiarrhythmic action mechanism of verapamil (Isoptin)].
    Bass O; Friedemann M
    Schweiz Med Wochenschr; 1971 May; 101(21):792-9. PubMed ID: 5143469
    [No Abstract]   [Full Text] [Related]  

  • 17. Electrophysiologic evaluation of antiarrhythmic drugs on supraventricular tachyarrhythmias.
    Hiejima K; Suzuki F; Takahashi M; Satake S
    Jpn Circ J; 1983 Jan; 47(1):98-104. PubMed ID: 6827776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of magnesium versus verapamil on supraventricular arrhythmias.
    Gullestad L; Birkeland K; Mølstad P; Høyer MM; Vanberg P; Kjekshus J
    Clin Cardiol; 1993 May; 16(5):429-34. PubMed ID: 8504578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electropharmacology of the slow-channel inhibitors in the management of cardiac arrhythmias: verapamil.
    Frishman WH; LeJemtel TH
    Pacing Clin Electrophysiol; 1982 May; 5(3):402-13. PubMed ID: 6179058
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium antagonists in patients with cardiovascular disease. Current perspectives.
    Winniford MD; Hillis LD
    Medicine (Baltimore); 1985 Jan; 64(1):61-73. PubMed ID: 3880854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.